Intrathecal magnesium delivery for Mg++-insensitive NMDA receptor activity due to GRIN1 mutation.
Intrathecal magnesium delivery for Mg++-insensitive NMDA receptor activity due to GRIN1 mutation.
复制标题
DOI:
10.1186/s13023-023-02756-9
复制
发表时间:
2023-08-03
影响因子:
3.7
通讯作者:
Kruer, Michael C.
中科院分区:
文献类型:
--
作者:
Lewis, Sara A.;Shetty, Sheetal;Gamble, Sean;Heim, Jennifer;Zhao, Ningning;Stitt, Gideon;Pankratz, Matthew;Mangum, Tara;Marku, Iris;Rosenberg, Robert B.;Wilfong, Angus A.;Fahey, Michael C.;Kim, Sukhan;Myers, Scott J.;Appavu, Brian;Kruer, Michael C.
关键词:
Mutations in the NMDA receptor are known to disrupt glutamatergic signaling crucial for early neurodevelopment, often leading to severe global developmental delay/intellectual disability, epileptic encephalopathy, and cerebral palsy phenotypes. Both seizures and movement disorders can be highly treatment-refractory. We describe a targeted ABA n-of-1 treatment trial with intrathecal MgSO4, rationally designed based on the electrophysiologic properties of this gain of function mutation in the GRIN1 NMDA subunit. Although the invasive nature of the trial necessitated a short-term, non-randomized, unblinded intervention, quantitative longitudinal neurophysiologic monitoring indicated benefit, providing class II evidence in support of intrathecal MgSO4 for select forms of GRIN disorders. The online version contains supplementary material available at 10.1186/s13023-023-02756-9.
登录
查看更多内容
影响因子:
3.7
作者:
FuchsBuder, T;Tramer, MR;Tassonyi, E
通讯作者:
Tassonyi, E
影响因子:
105.7
作者:
Vohra, Sunita;Shamseer, Larissa;Moher, David
通讯作者:
Moher, David
影响因子:
11
作者:
Mielnik CA;Binko MA;Chen Y;Funk AJ;Johansson EM;Intson K;Sivananthan N;Islam R;Milenkovic M;Horsfall W;Ross RA;Groc L;Salahpour A;McCullumsmith RE;Tripathy S;Lambe EK;Ramsey AJ
通讯作者:
Ramsey AJ
影响因子:
9.9
作者:
Müller AR;Brands MMMG;van de Ven PM;Roes KCB;Cornel MC;van Karnebeek CDM;Wijburg FA;Daams JG;Boot E;van Eeghen AM
通讯作者:
van Eeghen AM
影响因子:
9.8
作者:
Mercieri, M.;De Blasi, R. A.;Arcioni, R.
通讯作者:
Arcioni, R.